Skip to content

Author

D. Glintborg

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Higher PFAS Exposure Associated with Lower Aldosterone in Pregnant Women - the potential missing link with fetoplacental interaction? The Odense Child Cohort.

BACKGROUND Perfluoroalkyl substances (PFAS) are endocrine disrupting chemicals that may interfere with steroid hormone synthesis. Aldosterone is an essential steroid hormone during pregnancy and an independent determinant of placental and birth weight. OBJECTIVE To investigate associations between PFAS exposure in ea...

R. Jensen, Hajir Al-Jorani, D. Glintborg et al. · 0 citations
Review Open access Sep 2026

Hormonal target validation based on biochemical shifts in gender-affirming hormone therapy.

BACKGROUND Hormonal targets for gender-affirming hormone therapy (GAHT) remain largely unvalidated in gender-diverse individuals, with no clinical markers to assess dosing adequacy. We hypothesize that a biochemical shift towards the hormonal profile of the identified sex correlates with appropriate dosing. METHODS A...

Jeroen Vervalcke, L. Marinelli, D. Glintborg et al. · 0 citations
Review Open access Aug 2026

Assessing the Capacity of Health Facilities to Deliver Concomitant HPV Vaccination and HPV-Based Cervical Screening Services to Vulnerable Populations – An Implementation Research Protocol

This implementation research protocol offers a structured approach to assess the readiness of health systems to deliver combined HPV vaccination and HPV-based CC screening to vulnerable populations, and will allow the tailoring of strategies to strengthen CC prevention services.

Isabel Mosquera, A. Tisler, A. T. Ramírez et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.